“miR-484 suppresses proliferation and epithelial-mesenchymal transition by targeting ZEB1 and SMAD2 in cervical cancer cells” published in Cancer cell international was retracted as a result of concerns/issues about data and duplication of image. This evidence concerns the gene ZEB1 and cervical carcinoma.